Search results
AstraZeneca admits Covid-19 vaccine may cause blood clots in “very rare” cases
Pharmaceutical Technology via Yahoo Finance· 4 days agoAstraZeneca has been embroiled in a class action lawsuit for itsCovid-19 vaccine, admitting that the...
In a first, AstraZeneca admits its Covid vaccine can cause rare blood clots
The Independent via Yahoo News· 5 days agoSyndrome, involving unusual and severe blood clotting events associated with low platelet counts,...
AstraZeneca admits rare side effect of COVID-19 vaccine
Homenewshere.com· 2 days agoPharmaceutical company AstraZeneca acknowledged in U.K. court documents that its COVID-19 vaccine...
Supreme Court Rejects Military Chaplains' Lawsuit Claiming Refusal of COVID-19 Vaccine Hurt Their...
Military.com via Yahoo News· 5 days agoThe justices rejected a petition from 39 military chaplains who said they continue to face...
mRNA Vaccines: Not Just for COVID Soon?
Medscape· 3 days agoTo date, mRNA vaccines have had their largest global presence in combating the COVID-19 pandemic. Intensive research is underway on many ...
Helpful Tips to Secure Your Child’s Health and Future
Mercola· 3 hours agoIn this interview, Dr. Lawrence (Larry) Palevsky, a practicing pediatrician, discusses the impact that mainstream propaganda narratives have on our children, and why it's so important to get ...
CDC Found Evidence COVID-19 Vaccines Caused Deaths
WSAU Wausau· 4 days agoIn an exclusive report by the Epoch Times, U.S. Centers for Disease Control and Prevention (CDC) officials fou...
AstraZeneca admits in court documents that COVID-19 vaccine could cause serious rare side effect
Just the News· 3 days agoBritish pharmaceutical company AstraZeneca admitted in court documents for the first time that its ...
Moderna Stock Takes Minimal Hit After New COVID Vaccine Topped Projected Estimates
Black Enterprise· 2 days agoModerna announced an increase in stock price after their COVID vaccine exceeded sales estimates for...
Moderna COVID vaccine sales plummet 91 percent - The Boston Globe
The Boston Globe· 3 days agoSales of Moderna’s COVID-19 vaccine plunged 91 percent from the previous year for the first quarter...